Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Begier

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
BMJ Open|January 14, 2025
Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev StudyFirdaus Nabeemeeah, Nadia Sabet, Kennedy Otwombe, et al.
JAMA Network Open|December 13, 2024
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Lower Respiratory Tract DiseaseSara Y Tartof, Negar Aliabadi, Gabriella Goodwin, et al.
The Journal of Infectious Diseases|April 18, 2025
Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study's Final AnalysisElizabeth Begier, Negar Aliabadi, Julio Ramirez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older AdultsAshley Tippett, Gabby Ess, Laila Hussaini, et al.
Open Forum Infectious Diseases|July 14, 2025
Viral Etiologies of Acute Respiratory Illness in Older Adults and of Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization During 2 Prepandemic Respiratory SeasonsChris Choi, Gabriella Ess, Ashley Tippett, et al.
American Heart Journal|July 30, 2025
A pragmatic individually randomized trial to evaluate bivalent RSV prefusion F protein-based vaccine effectiveness for preventing RSV hospitalizations in adults aged 60 years or above (DAN-RSV): Rationale and trial designMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Plos One|January 27, 2023
Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: An observational cohort studyNaomi F Walker, Rachel L Byrne, Ashleigh Howard, et al.
The Journal of Infectious Diseases|July 12, 2024
Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United StatesEvan J Anderson, Ashley Tippett, Elizabeth Begier, et al.
Infectious Diseases and Therapy|July 7, 2026
Viral Pathogen-Specific Severe Acute Respiratory Infections in Hospitalised Adults in Europe: Epidemiological Findings from the id.DRIVE Study 2024-2025Katherine Newell, Nikki Vroom, Cátia Marques, et al.
The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
BMJ Open|January 14, 2025
Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev StudyFirdaus Nabeemeeah, Nadia Sabet, Kennedy Otwombe, et al.
JAMA Network Open|December 13, 2024
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Lower Respiratory Tract DiseaseSara Y Tartof, Negar Aliabadi, Gabriella Goodwin, et al.
The Journal of Infectious Diseases|April 18, 2025
Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study's Final AnalysisElizabeth Begier, Negar Aliabadi, Julio Ramirez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older AdultsAshley Tippett, Gabby Ess, Laila Hussaini, et al.
Open Forum Infectious Diseases|July 14, 2025
Viral Etiologies of Acute Respiratory Illness in Older Adults and of Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization During 2 Prepandemic Respiratory SeasonsChris Choi, Gabriella Ess, Ashley Tippett, et al.
American Heart Journal|July 30, 2025
A pragmatic individually randomized trial to evaluate bivalent RSV prefusion F protein-based vaccine effectiveness for preventing RSV hospitalizations in adults aged 60 years or above (DAN-RSV): Rationale and trial designMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Plos One|January 27, 2023
Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: An observational cohort studyNaomi F Walker, Rachel L Byrne, Ashleigh Howard, et al.
The Journal of Infectious Diseases|July 12, 2024
Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United StatesEvan J Anderson, Ashley Tippett, Elizabeth Begier, et al.
Infectious Diseases and Therapy|July 7, 2026
Viral Pathogen-Specific Severe Acute Respiratory Infections in Hospitalised Adults in Europe: Epidemiological Findings from the id.DRIVE Study 2024-2025Katherine Newell, Nikki Vroom, Cátia Marques, et al.
The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.
Pageof 14